Researchers at MUSC Hollings Cancer Center, led by Noel Warfel, Ph.D. revealed a previously unknown mechanism that helps prostate cancer cells evade treatment and points to a potential strategy for overcoming that resistance.
Researchers at the University of Cologne’s Center for Molecular Medicine Cologne (CMMC) have discovered a previously unknown mechanism that makes most pancreatic cancer cells susceptible to a form of programmed cell death.
A study led by Georgia Institute of Technology’s Associate Professor Costas Arvanitis takes a major step toward safer and more effective treatment and diagnosis of brain diseases. His team’s research, published in Advanced Science, shows how combining artificial intelligence (AI) with focused ultrasound can safely deliver therapies and improve diagnostic interventions to the brain.
Now, scientists at the La Jolla Institute for Immunology in California report that a live-attenuated flu vaccine administered as a nasal spray may establish a durable local immune memory in the respiratory tract, potentially strengthening defenses where the infection starts.
Dexcom (Nadsaq:DXCM) has received FDA clearance for its Stelo over-the-counter (OTC) continuous glucose monitor (CGM) for children.
SurGenTec announced today that the FDA cleared its ION-L lumbar facet fixation system for degenerative disc disease (DDD).
Tumor cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer drugs. In some types of the disease, such as certain forms of lung cancer, this state is triggered by stress hormones in the body. Inside the cancer cells, glucocorticoid receptors recognize the hormones, and the cells respond by lapsing into a state in which they undergo barely any division. This renders many treatments ineffective.
Scientists are attempting to switch off these receptors with a view to waking the cancer cells up from sleep—making them vulnerable to attack.
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.
In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect core body temperature. Measuring core temperature from within the body could make it easier to determine whether someone is sick and whether they’re at risk of spiking a dangerous fever.
Deep brain stimulation (DBS) has been used for more than three decades to treat motor symptoms of Parkinson’s disease. Today, more than 200,000 patients worldwide have been implanted with these systems, which continuously deliver electrical stimulation to specific deep-brain regions to reduce rigidity and tremor. Yet despite its clinical success, conventional deep brain stimulation remains limited in its ability to address one of the disease’s most disabling symptoms: walking impairments.